These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31562496)

  • 21. Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects.
    Simmler LD; Hysek CM; Liechti ME
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2844-50. PubMed ID: 21715530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasopressin and Copeptin in health and disease.
    Christ-Crain M
    Rev Endocr Metab Disord; 2019 Sep; 20(3):283-294. PubMed ID: 31656992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease.
    Piani F; Reinicke T; Lytvyn Y; Melena I; Lovblom LE; Lai V; Tse J; Cham L; Orszag A; Perkins BA; Cherney DZI; Bjornstad P
    J Diabetes Complications; 2021 Mar; 35(3):107807. PubMed ID: 33288413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic alpha-cell function in idiopathic reactive hypoglycemia.
    Ahmadpour S; Kabadi UM
    Metabolism; 1997 Jun; 46(6):639-43. PubMed ID: 9186298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in copeptin and bioactive vasopressin in runners with and without hyponatremia.
    Hew-Butler T; Hoffman MD; Stuempfle KJ; Rogers IR; Morgenthaler NG; Verbalis JG
    Clin J Sport Med; 2011 May; 21(3):211-7. PubMed ID: 21519298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
    Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired counterregulatory responses to hypoglycaemia following oral glucose in adults with cystic fibrosis.
    Aitken ML; Szkudlinska MA; Boyko EJ; Ng D; Utzschneider KM; Kahn SE
    Diabetologia; 2020 May; 63(5):1055-1065. PubMed ID: 31993716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Octreotide suppresses the incretin glucagon-like peptide (7-36) amide in patients with acromegaly or clinically nonfunctioning pituitary tumors and in healthy subjects.
    Plöckinger U; Holst JJ; Messerschmidt D; Hopfenmüller W; Quabbe HJ
    Eur J Endocrinol; 1999 Jun; 140(6):538-44. PubMed ID: 10377503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postprandial glucose, insulin and incretin responses to different carbohydrate tolerance tests.
    Deng Y; Zhang Y; Zheng S; Hong J; Wang C; Liu T; Sun Z; Gu W; Gu Y; Shi J; Yao S; Wang W; Ning G
    J Diabetes; 2015 Nov; 7(6):820-9. PubMed ID: 25395350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute fructose administration decreases the glycemic response to an oral glucose tolerance test in normal adults.
    Moore MC; Cherrington AD; Mann SL; Davis SN
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4515-9. PubMed ID: 11134101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GLP-1 does not not acutely affect insulin sensitivity in healthy man.
    Orskov L; Holst JJ; Møller J; Orskov C; Møller N; Alberti KG; Schmitz O
    Diabetologia; 1996 Oct; 39(10):1227-32. PubMed ID: 8897012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heat acclimatization blunts copeptin responses to hypertonicity from dehydrating exercise in humans.
    Stacey MJ; Woods DR; Brett SJ; Britland SE; Fallowfield JL; Allsopp AJ; Delves SK
    Physiol Rep; 2018 Sep; 6(18):e13851. PubMed ID: 30221840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of vasopressin infusion on glucose metabolism in man.
    Spruce BA; McCulloch AJ; Burd J; Orskov H; Heaton A; Baylis PH; Alberti KG
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):463-8. PubMed ID: 3886209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Copeptin, a surrogate marker for arginine vasopressin secretion, is associated with higher glucose and insulin concentrations but not higher blood pressure in obese men.
    Asferg CL; Andersen UB; Linneberg A; Goetze JP; Jeppesen JL
    Diabet Med; 2014 Jun; 31(6):728-32. PubMed ID: 24533694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus.
    Elias LL; Antunes-Rodrigues J; Elias PC; Moreira AC
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1243-7. PubMed ID: 9100602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.
    Abdul-Ghani MA; Williams K; DeFronzo R; Stern M
    Diabetes Care; 2006 Jul; 29(7):1613-8. PubMed ID: 16801587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial.
    Kuwata H; Iwasaki M; Shimizu S; Minami K; Maeda H; Seino S; Nakada K; Nosaka C; Murotani K; Kurose T; Seino Y; Yabe D
    Diabetologia; 2016 Mar; 59(3):453-61. PubMed ID: 26704625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study.
    Berton AM; Parasiliti-Caprino M; Prencipe N; Bioletto F; Lopez C; Bona C; Caputo M; Rumbolo F; Ponzetto F; Settanni F; Gasco V; Mengozzi G; Ghigo E; Grottoli S; Maccario M; Benso AS
    Front Neurosci; 2023; 17():1098404. PubMed ID: 37021137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.